| Year |
Citation |
Score |
| 2024 |
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J. Publisher Correction: Hazardous drinking and alcohol use disorders. Nature Reviews. Disease Primers. 10: 69. PMID 39304664 DOI: 10.1038/s41572-024-00561-7 |
0.492 |
|
| 2024 |
Grodin EN, McManus KR, Ray LA. Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder. Addiction Biology. 29: e13431. PMID 39091190 DOI: 10.1111/adb.13431 |
0.463 |
|
| 2024 |
Belnap MA, McManus KR, Grodin EN, Ray LA. Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder. Pharmaceutical Medicine. PMID 38967906 DOI: 10.1007/s40290-024-00526-x |
0.506 |
|
| 2024 |
Kady A, Grodin EN, Ray LA. Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo. Alcohol and Alcoholism (Oxford, Oxfordshire). 59. PMID 38953743 DOI: 10.1093/alcalc/agae044 |
0.376 |
|
| 2024 |
Heilig M, Witkiewitz K, Ray LA, Leggio L. Novel medications for problematic alcohol use. The Journal of Clinical Investigation. 134. PMID 38828724 DOI: 10.1172/JCI172889 |
0.45 |
|
| 2024 |
Kirsch DE, Grodin EN, Nieto SJ, Kady A, Ray LA. Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 38740901 DOI: 10.1038/s41386-024-01877-4 |
0.702 |
|
| 2024 |
Grodin EN, Baskerville WA, Meredith LR, Nieto S, Ray LA. Reward, relief, and habit drinking profiles in treatment seeking individuals with an AUD. Alcohol and Alcoholism (Oxford, Oxfordshire). 59. PMID 38725398 DOI: 10.1093/alcalc/agae032 |
0.745 |
|
| 2024 |
Grodin EN, Burnette EM, Rodriguez C, Fulcher JA, Ray LA. The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies. Alcohol, Clinical & Experimental Research. PMID 38719790 DOI: 10.1111/acer.15338 |
0.441 |
|
| 2024 |
Grodin EN, Kirsch D, Belnap M, Ray LA. Sex differences in neural response to an acute stressor in individuals with an alcohol use disorder. Alcohol, Clinical & Experimental Research. 48: 843-854. PMID 38652235 DOI: 10.1111/acer.15301 |
0.354 |
|
| 2024 |
Kirsch DE, Grodin EN, Ray LA. Characterizing alcohol cue reactive and non-reactive individuals with alcohol use disorder. Addictive Behaviors. 155: 108028. PMID 38640885 DOI: 10.1016/j.addbeh.2024.108028 |
0.536 |
|
| 2024 |
Nieto SJ, Du H, Meredith LR, Donato S, Magill M, Ray LA. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy. Psychopharmacology. PMID 38613685 DOI: 10.1007/s00213-024-06589-7 |
0.766 |
|
| 2024 |
Nieto SJ, Grodin EN, Ray LA. Neural Correlates of the Addictions Neuroclinical Assessment (ANA) Incentive Salience Factor Among Individuals with Alcohol Use Disorder. Behavioural Brain Research. 114926. PMID 38431152 DOI: 10.1016/j.bbr.2024.114926 |
0.772 |
|
| 2024 |
Kirsch DE, Ray LA, Wassum KM, Grodin EN. Anterior cingulate and medial prefrontal cortex alcohol cue reactivity varies as a function of drink preference in alcohol use disorder. Drug and Alcohol Dependence. 256: 111123. PMID 38367535 DOI: 10.1016/j.drugalcdep.2024.111123 |
0.493 |
|
| 2024 |
Baskerville WA, Grodin EN, Ray LA. Influence of sleep quality on lapse to alcohol use during a quit attempt. Alcohol and Alcoholism (Oxford, Oxfordshire). 59. PMID 38366914 DOI: 10.1093/alcalc/agae009 |
0.383 |
|
| 2023 |
Donato S, Ray LA. Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base. Substance Abuse and Rehabilitation. 14: 157-166. PMID 38026786 DOI: 10.2147/SAR.S409943 |
0.316 |
|
| 2023 |
Ray LA, Baskerville WA, Nieto SJ, Grodin E, Enders C, Kady A, Meredith L, Gillis A, Leventhal A, Ho D, Miotto K. A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. Psychopharmacology. PMID 38012333 DOI: 10.1007/s00213-023-06504-6 |
0.732 |
|
| 2023 |
Burnette EM, Grodin EN, Olmstead R, Ray LA, Irwin MR. Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge. Alcohol, Clinical & Experimental Research. 47: 1859-1868. PMID 37864529 DOI: 10.1111/acer.15173 |
0.33 |
|
| 2023 |
Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. Response to Letter to the Editors regarding 'A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis'. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 37794750 DOI: 10.1093/alcalc/agad066 |
0.385 |
|
| 2023 |
Ray LA, Nieto SJ, Meredith LR, Burnette E, Donato S, Magill M, Du H. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study. Psychopharmacology. PMID 37452887 DOI: 10.1007/s00213-023-06409-4 |
0.773 |
|
| 2023 |
Meredith LR, Burnette EM, Nieto SJ, Du H, Donato S, Grodin EN, Green R, Magill M, Baskerville WA, Ray LA. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol (Hanover, York County, Pa.). PMID 37423771 DOI: 10.1111/acer.15143 |
0.736 |
|
| 2023 |
Baskerville WA, Grodin EN, Lin J, Miotto K, Mooney LJ, Ray LA. Alcohol Use Among Treatment-Seeking Individuals with Opioid Use Disorder. Journal of Studies On Alcohol and Drugs. PMID 37096768 DOI: 10.15288/jsad.22-00176 |
0.439 |
|
| 2023 |
Grodin EN, Burnette EM, O'Neill J, Alger J, Ray LA. Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 36939375 DOI: 10.1093/alcalc/agad014 |
0.485 |
|
| 2023 |
Lékó AH, Ray LA, Leggio L. The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications? Alcoholism, Clinical and Experimental Research. PMID 36882163 DOI: 10.1111/acer.15049 |
0.422 |
|
| 2023 |
Magill M, Kiluk BD, Ray LA. Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate? Substance Abuse and Rehabilitation. 14: 1-11. PMID 36844999 DOI: 10.2147/SAR.S362864 |
0.363 |
|
| 2022 |
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J. Hazardous drinking and alcohol use disorders. Nature Reviews. Disease Primers. 8: 80. PMID 36550121 DOI: 10.1038/s41572-022-00406-1 |
0.446 |
|
| 2022 |
Venegas A, Ray LA. Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach. Experimental and Clinical Psychopharmacology. PMID 36534416 DOI: 10.1037/pha0000621 |
0.535 |
|
| 2022 |
Nieto SJ, Enders CK, Witkiewitz K, O'Malley SS, Ray LA. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, Clinical and Experimental Research. 46: 2258-2266. PMID 36515648 DOI: 10.1111/acer.14953 |
0.751 |
|
| 2022 |
Ray LA, Nieto SJ, Grodin EN. Translational models of addiction phenotypes to advance addiction pharmacotherapy. Annals of the New York Academy of Sciences. PMID 36385614 DOI: 10.1111/nyas.14929 |
0.732 |
|
| 2022 |
Grodin EN, Meredith LR, Burnette EM, Miotto K, Irwin MR, Ray LA. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. The American Journal of Drug and Alcohol Abuse. 1-12. PMID 36282988 DOI: 10.1080/00952990.2022.2124918 |
0.482 |
|
| 2022 |
Donato S, Nieto S, Ray LA. The Brief Alcohol Use Disorder Severity Scale: An Initial Validation Evaluation. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 36063825 DOI: 10.1093/alcalc/agac039 |
0.729 |
|
| 2022 |
Venegas A, Du H, Cooper ZD, Ray LA. Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers. Addictive Behaviors. 135: 107443. PMID 35932601 DOI: 10.1016/j.addbeh.2022.107443 |
0.407 |
|
| 2022 |
Nieto SJ, Grodin EN, Burnette EM, Cahill CM, Ray LA. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 35788255 DOI: 10.1093/alcalc/agac029 |
0.77 |
|
| 2022 |
Grodin EN, Nieto SJ, Meredith LR, Burnette E, O'Neill J, Alger J, London ED, Miotto K, Evans CJ, Irwin MR, Ray LA. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addiction Biology. 27: e13182. PMID 35754106 DOI: 10.1111/adb.13182 |
0.698 |
|
| 2022 |
Leventhal AM, Cho J, Ray LA, Liccardo Pacula R, Lee BP, Terrault N, Pedersen E, Lee JO, Davis JP, Jin H, Huh J, Wilson JP, Whaley RC. Alcohol use trajectories among U.S. adults during the first 42 weeks of the COVID-19 pandemic. Alcoholism, Clinical and Experimental Research. PMID 35532741 DOI: 10.1111/acer.14824 |
0.313 |
|
| 2022 |
Nieto SJ, Venegas A, Hudson J, Ray LA. Cannabis use and subjective response to alcohol in the human laboratory. Drug and Alcohol Dependence. 236: 109481. PMID 35523112 DOI: 10.1016/j.drugalcdep.2022.109481 |
0.785 |
|
| 2022 |
Nieto SJ, Ray LA. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Behavioural Brain Research. 427: 113876. PMID 35378110 DOI: 10.1016/j.bbr.2022.113876 |
0.689 |
|
| 2022 |
Meredith LR, Grodin EN, Montoya AK, Miranda R, Squeglia LM, Towns B, Evans C, Ray LA. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment. Alcoholism, Clinical and Experimental Research. PMID 35362101 DOI: 10.1111/acer.14821 |
0.499 |
|
| 2022 |
Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 35229869 DOI: 10.1093/alcalc/agac004 |
0.386 |
|
| 2022 |
Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs. PMID 35133639 DOI: 10.1007/s40265-021-01670-3 |
0.721 |
|
| 2022 |
Nieto SJ, Grodin EN, Ho D, Baskerville WA, Ray LA. Moderators of subjective response to alcohol in the human laboratory. Alcoholism, Clinical and Experimental Research. PMID 35084054 DOI: 10.1111/acer.14783 |
0.784 |
|
| 2021 |
Meredith LR, Green R, Grodin EN, Chorpita M, Miotto K, Ray LA. Ibudilast moderates the effect of mood on alcohol craving during stress exposure. Experimental and Clinical Psychopharmacology. PMID 36102596 DOI: 10.1037/pha0000458 |
0.47 |
|
| 2021 |
Green R, Montoya AK, Ray LA. The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reduction. Experimental and Clinical Psychopharmacology. PMID 34968106 DOI: 10.1037/pha0000536 |
0.309 |
|
| 2021 |
Nieto SJ, Venegas A, Burnette EM, MacKillop J, Ray LA. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers. Psychopharmacology. PMID 34652499 DOI: 10.1007/s00213-021-05993-7 |
0.727 |
|
| 2021 |
Nieto SJ, Grodin EN, Aguirre CG, Izquierdo A, Ray LA. Translational opportunities in animal and human models to study alcohol use disorder. Translational Psychiatry. 11: 496. PMID 34588417 DOI: 10.1038/s41398-021-01615-0 |
0.676 |
|
| 2021 |
Burnette EM, Ray LA, Irwin MR, Grodin EN. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder. Alcoholism, Clinical and Experimental Research. PMID 34585396 DOI: 10.1111/acer.14696 |
0.516 |
|
| 2021 |
Donato S, Green R, Ray LA. Alcohol use disorder severity moderates clinical response to varenicline. Alcoholism, Clinical and Experimental Research. PMID 34486130 DOI: 10.1111/acer.14674 |
0.538 |
|
| 2021 |
Venegas A, Donato S, Meredith LR, Ray LA. Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. The American Journal of Drug and Alcohol Abuse. 1-16. PMID 34464542 DOI: 10.1080/00952990.2021.1969658 |
0.351 |
|
| 2021 |
Grodin EN, Burnette E, Towns B, Venegas A, Ray LA. Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 34435833 DOI: 10.1037/adb0000743 |
0.493 |
|
| 2021 |
Meredith LR, Grodin EN, Karno MP, Montoya AK, MacKillop J, Lim AC, Ray LA. Preliminary study of alcohol problem severity and response to brief intervention. Addiction Science & Clinical Practice. 16: 54. PMID 34429151 DOI: 10.1186/s13722-021-00262-6 |
0.449 |
|
| 2021 |
Meredith LR, Burnette EM, Grodin EN, Irwin MR, Ray LA. Immune Treatments for Alcohol Use Disorder: A Translational Framework. Brain, Behavior, and Immunity. PMID 34343618 DOI: 10.1016/j.bbi.2021.07.023 |
0.374 |
|
| 2021 |
Grodin EN, Burnette EM, Green R, Lim AC, Miotto K, Ray LA. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. Drug and Alcohol Dependence. 225: 108825. PMID 34175784 DOI: 10.1016/j.drugalcdep.2021.108825 |
0.553 |
|
| 2021 |
Ray LA, Green R, Grodin E. Neurobiological Models of Alcohol Use Disorder in Humans. The American Journal of Psychiatry. 178: 483-484. PMID 34154380 DOI: 10.1176/appi.ajp.2021.21030310 |
0.451 |
|
| 2021 |
Nieto SJ, Baskerville W, Donato S, Bujarski S, Ray L. Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 34134588 DOI: 10.1080/00952990.2021.1938100 |
0.79 |
|
| 2021 |
Green R, Du H, Grodin EN, Nieto SJ, Bujarski S, Roche DJO, Ray LA. A meta-regression of methodological features predicting the effects of pharmacotherapies on subjective response to alcohol. Alcoholism, Clinical and Experimental Research. PMID 34120356 DOI: 10.1111/acer.14643 |
0.785 |
|
| 2021 |
Grodin EN, Bujarski S, Towns B, Burnette E, Nieto S, Lim A, Lin J, Miotto K, Gillis A, Irwin MR, Evans C, Ray LA. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational Psychiatry. 11: 355. PMID 34120149 DOI: 10.1038/s41398-021-01478-5 |
0.775 |
|
| 2021 |
Ray LA, Green R, Enders C, Leventhal AM, Grodin EN, Li G, Lim A, Hartwell E, Venegas A, Meredith L, Nieto SJ, Shoptaw S, Ho D, Miotto K. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. The American Journal of Psychiatry. appiajp202020070993. PMID 34080890 DOI: 10.1176/appi.ajp.2020.20070993 |
0.686 |
|
| 2021 |
Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. Erratum to: Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 33876816 DOI: 10.1093/alcalc/agab035 |
0.314 |
|
| 2021 |
Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 33778869 DOI: 10.1093/alcalc/agab016 |
0.365 |
|
| 2021 |
Nieto SJ, Grodin EN, Green R, Ray LA. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug and Alcohol Dependence. 221: 108603. PMID 33618192 DOI: 10.1016/j.drugalcdep.2021.108603 |
0.73 |
|
| 2021 |
Burnette EM, Grodin EN, Eisenberger NI, Ray LA. Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 33592623 DOI: 10.1093/alcalc/agaa148 |
0.446 |
|
| 2020 |
Nieto SJ, Grodin EN, Ray LA. On the path towards personalized medicine: Implications of pharmacogenetic studies of alcohol use disorder medications. Expert Review of Precision Medicine and Drug Development. 5: 43-54. PMID 34291172 DOI: 10.1080/23808993.2020.1724510 |
0.723 |
|
| 2020 |
Green R, MacKillop J, Hartwell EE, Lim AC, Baskerville WA, Karno M, Ray LA. Behavioral Economic Demand for Alcohol and Cigarettes in Heavy Drinking Smokers: Evidence of Asymmetric Cross-commodity Reinforcing Value. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33247757 DOI: 10.1093/ntr/ntaa049 |
0.469 |
|
| 2020 |
Ray LA, Du H, Green R, Roche DJO, Bujarski S. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33235284 DOI: 10.1038/s41386-020-00913-3 |
0.441 |
|
| 2020 |
Ho D, Towns B, Grodin EN, Ray LA. A novel human laboratory model for screening medications for alcohol use disorder. Trials. 21: 947. PMID 33225963 DOI: 10.1186/s13063-020-04842-w |
0.38 |
|
| 2020 |
Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, London ED. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and Alcohol Dependence. 108391. PMID 33153830 DOI: 10.1016/j.drugalcdep.2020.108391 |
0.318 |
|
| 2020 |
Nieto SJ, Green R, Grodin EN, Cahill CM, Ray LA. Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug and Alcohol Dependence. 108368. PMID 33143942 DOI: 10.1016/j.drugalcdep.2020.108368 |
0.689 |
|
| 2020 |
Burnette EM, Grodin EN, Schacht JP, Ray LA. Clinical and neural correlates of reward and relief drinking. Alcoholism, Clinical and Experimental Research. PMID 33119924 DOI: 10.1111/acer.14495 |
0.428 |
|
| 2020 |
Baskerville WA, Nieto SJ, Ho D, Towns B, Grodin EN, Li C, Burnette E, Donato S, Ray LA. Baseline Drinking Patterns in Non-Treatment Seeking Problem Drinkers. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 33016306 DOI: 10.1093/alcalc/agaa098 |
0.683 |
|
| 2020 |
Nieto SJ, Green R, MacKillop J, Ray LA. Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals with Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 32945536 DOI: 10.1111/Acer.14460 |
0.803 |
|
| 2020 |
Grodin EN, Green R, Ray LA. An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol. Alcoholism, Clinical and Experimental Research. PMID 32944932 DOI: 10.1111/Acer.14458 |
0.576 |
|
| 2020 |
Burnette EM, Baskerville WA, Grodin EN, Ray LA. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial. Trials. 21: 779. PMID 32912290 DOI: 10.1186/S13063-020-04670-Y |
0.512 |
|
| 2020 |
Meredith LR, Lim AC, Ray LA. Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences. Drug and Alcohol Dependence. 216: 108269. PMID 32906037 DOI: 10.1016/J.Drugalcdep.2020.108269 |
0.56 |
|
| 2020 |
Bello MS, Liautaud MM, De La Cerda JT, Pang RD, Ray LA, Ahluwalia JA, Leventhal AM. Association of Frequency of Perceived Exposure to Discrimination with Tobacco Withdrawal Symptoms and Smoking Lapse Behavior in African Americans. Addiction (Abingdon, England). PMID 32860477 DOI: 10.1111/Add.15238 |
0.322 |
|
| 2020 |
Kramer J, Dick DM, King A, Ray LA, Sher KJ, Vena A, Vendruscolo LF, Acion L. Mechanisms of Alcohol Addiction: Bridging Human and Animal Studies. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 32781467 DOI: 10.1093/Alcalc/Agaa068 |
0.663 |
|
| 2020 |
Grodin EN, Montoya AK, Bujarski S, Ray LA. Modeling motivation for alcohol in humans using traditional and machine learning approaches. Addiction Biology. e12949. PMID 32725863 DOI: 10.1111/Adb.12949 |
0.589 |
|
| 2020 |
Venegas A, Meredith LR, Green R, Cooper ZD, Ray LA. Sex-dependent effects of alcohol administration on the urge to use cannabis. Experimental and Clinical Psychopharmacology. PMID 32658530 DOI: 10.1037/Pha0000409 |
0.593 |
|
| 2020 |
Aguirre CG, Stolyarova A, Das K, Kolli S, Marty V, Ray L, Spigelman I, Izquierdo A. Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal. Plos One. 15: e0234729. PMID 32555668 DOI: 10.1371/Journal.Pone.0234729 |
0.437 |
|
| 2020 |
Magill M, Tonigan JS, Kiluk B, Ray L, Walthers J, Carroll K. The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review. Behaviour Research and Therapy. 131: 103648. PMID 32474226 DOI: 10.1016/J.Brat.2020.103648 |
0.455 |
|
| 2020 |
Grodin EN, Nguyen XT, Ho D, Bujarski S, Ray LA. Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers. Addictive Behaviors Reports. 11: 100249. PMID 32467838 DOI: 10.1016/J.Abrep.2020.100249 |
0.5 |
|
| 2020 |
Lim AC, Green R, Grodin EN, Venegas A, Meredith LR, Donato S, Burnette E, Ray LA. Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration. Alcoholism, Clinical and Experimental Research. PMID 32406553 DOI: 10.1111/Acer.14342 |
0.581 |
|
| 2020 |
Lim AC, Grodin EN, Green R, Venegas A, Meredith LR, Courtney KE, Moallem NR, Sayegh P, London ED, Ray LA. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. The American Journal of Drug and Alcohol Abuse. 1-12. PMID 32343625 DOI: 10.1080/00952990.2020.1741002 |
0.386 |
|
| 2020 |
Venegas A, Meredith LR, Cooper ZD, Towns B, Ray LA. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 32328657 DOI: 10.1093/Alcalc/Agaa023 |
0.571 |
|
| 2020 |
Ray LA, Grodin EN, Leggio L, Bechtholt AJ, Becker H, Feldstein Ewing SW, Jentsch JD, King AC, Mason BJ, O'Malley S, MacKillop J, Heilig M, Koob GF. The future of translational research on alcohol use disorder. Addiction Biology. e12903. PMID 32286721 DOI: 10.1111/Adb.12903 |
0.607 |
|
| 2020 |
Glasner S, Chokron Garneau H, Ang A, Ray L, Venegas A, Rawson R, Kalichman S. Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial. Plos One. 15: e0229557. PMID 32163431 DOI: 10.1371/Journal.Pone.0229557 |
0.388 |
|
| 2020 |
Nieto SJ, Grodin EN, Ray LA. On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medications Expert Review of Precision Medicine and Drug Development. 5: 43-54. DOI: 10.1080/23808993.2020.1724510 |
0.747 |
|
| 2019 |
Ray LA, Du H, Grodin E, Bujarski S, Meredith L, Ho D, Nieto S, Wassum K. Capturing habitualness of drinking and smoking behavior in humans. Drug and Alcohol Dependence. 207: 107738. PMID 31816490 DOI: 10.1016/J.Drugalcdep.2019.107738 |
0.705 |
|
| 2019 |
Cummings JR, Gearhardt AN, Ray LA, Choi AK, Tomiyama AJ. Experimental and observational studies on alcohol use and dietary intake: a systematic review. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. PMID 31691442 DOI: 10.1111/Obr.12950 |
0.524 |
|
| 2019 |
Burnette EM, Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. Association between impulsivity and neural activation to alcohol cues in heavy drinkers. Psychiatry Research. Neuroimaging. 293: 110986. PMID 31622796 DOI: 10.1016/J.Pscychresns.2019.110986 |
0.563 |
|
| 2019 |
Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of Consulting and Clinical Psychology. PMID 31599606 DOI: 10.1037/Ccp0000447 |
0.428 |
|
| 2019 |
Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis. Alcoholism, Clinical and Experimental Research. PMID 31566787 DOI: 10.1111/Acer.14189 |
0.469 |
|
| 2019 |
Grodin EN, Bujarski S, Venegas A, Baskerville WA, Nieto SJ, Jentsch JD, Ray LA. Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 31557278 DOI: 10.1093/Alcalc/Agz075 |
0.789 |
|
| 2019 |
Cummings JR, Ray LA, Nooteboom P, Tomiyama AJ. Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. PMID 31504090 DOI: 10.1093/Abm/Kaz031 |
0.591 |
|
| 2019 |
Grodin EN, Ray LA. The Use of Functional Magnetic Resonance Imaging (fMRI) to Test Pharmacotherapies for Alcohol Use Disorders: A Systematic Review. Alcoholism, Clinical and Experimental Research. PMID 31386215 DOI: 10.1111/Acer.14167 |
0.464 |
|
| 2019 |
Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Ragnhild B, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, ... ... Ray LA, et al. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neuroscience and Biobehavioral Reviews. PMID 31319124 DOI: 10.1016/J.Neubiorev.2019.07.006 |
0.325 |
|
| 2019 |
Hartwell EE, Bujarski S, Green R, Ray LA. Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving. Addictive Behaviors Reports. 10: 100198. PMID 31304230 DOI: 10.1016/J.Abrep.2019.100198 |
0.57 |
|
| 2019 |
Venegas A, Ray LA. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 31295037 DOI: 10.1080/00952990.2019.1635138 |
0.519 |
|
| 2019 |
Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Frontiers in Psychiatry. 10: 408. PMID 31244697 DOI: 10.3389/Fpsyt.2019.00408 |
0.427 |
|
| 2019 |
Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug and Alcohol Dependence. PMID 31160146 DOI: 10.1016/J.Drugalcdep.2019.02.028 |
0.485 |
|
| 2019 |
Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis. Addiction Biology. PMID 31148304 DOI: 10.1111/Adb.12747 |
0.559 |
|
| 2019 |
Roche DJO, Bujarski S, Green R, Hartwell EE, Leventhal AM, Ray LA. Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co- and tri-use. Drug and Alcohol Dependence. 200: 40-49. PMID 31085377 DOI: 10.1016/J.Drugalcdep.2019.02.035 |
0.588 |
|
| 2019 |
Green R, Grodin E, Lim AC, Venegas A, Bujarski S, Krull J, Ray LA. The interplay between subjective response to alcohol, craving, and alcohol self-administration in the human laboratory. Alcoholism, Clinical and Experimental Research. PMID 30860603 DOI: 10.1111/Acer.14001 |
0.562 |
|
| 2019 |
Green R, Bujarski S, Lim AC, Venegas A, Ray LA. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Experimental and Clinical Psychopharmacology. PMID 30628813 DOI: 10.1037/Pha0000252 |
0.622 |
|
| 2019 |
Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse. 45: 124-140. PMID 30373394 DOI: 10.1080/00952990.2018.1528265 |
0.535 |
|
| 2018 |
Lim AC, Roche DJO, Ray LA. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers. Journal of Studies On Alcohol and Drugs. 79: 918-928. PMID 30573023 |
0.43 |
|
| 2018 |
Grodin EN, Ray LA, MacKillop J, Lim AC, Karno MP. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcoholism, Clinical and Experimental Research. PMID 30556913 DOI: 10.1111/Acer.13941 |
0.509 |
|
| 2018 |
Ray LA, Lim AC, Shoptaw S. What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'. Addiction (Abingdon, England). PMID 30426617 DOI: 10.1111/Add.14455 |
0.327 |
|
| 2018 |
Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, ... Ray L, et al. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial assessing Efficacy and Safety. Alcoholism, Clinical and Experimental Research. PMID 30403402 DOI: 10.1111/Acer.13917 |
0.538 |
|
| 2018 |
Lim AC, Courtney KE, Moallem NR, Allen VC, Leventhal AM, Ray LA. A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability. Frontiers in Psychiatry. 9: 362. PMID 30147661 DOI: 10.3389/Fpsyt.2018.00362 |
0.44 |
|
| 2018 |
Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 29969156 DOI: 10.1111/Acer.13829 |
0.469 |
|
| 2018 |
Allen VC, Ray LA, Myers HF. Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcoholism, Clinical and Experimental Research. PMID 29924387 DOI: 10.1111/Acer.13795 |
0.467 |
|
| 2018 |
Hartwell EE, Ray LA. Relationship between tonic and phasic craving for alcohol. Addictive Behaviors Reports. 7: 71-74. PMID 29892699 DOI: 10.1016/J.Abrep.2018.03.001 |
0.588 |
|
| 2018 |
Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29802367 DOI: 10.1038/S41386-018-0086-9 |
0.582 |
|
| 2018 |
Cummings JR, Tomiyama AJ, Ray LA. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. Journal of Addiction Medicine. PMID 29794557 DOI: 10.1097/Adm.0000000000000416 |
0.556 |
|
| 2018 |
Green R, Ray LA. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes. Drug and Alcohol Dependence. 188: 53-59. PMID 29751347 DOI: 10.1016/J.Drugalcdep.2018.03.037 |
0.338 |
|
| 2018 |
Moallem NR, Courtney KE, Ray LA. The relationship between impulsivity and methamphetamine use severity in a community sample. Drug and Alcohol Dependence. 187: 1-7. PMID 29626740 DOI: 10.1016/J.Drugalcdep.2018.01.034 |
0.315 |
|
| 2018 |
Lim AC, Roche DJO, Ray LA. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers. Journal of Studies On Alcohol and Drugs. 79: 918-928. DOI: 10.15288/Jsad.2018.79.918 |
0.496 |
|
| 2018 |
Ray LA, Roche DJO. Neurobiology of Craving: Current Findings and New Directions Current Addiction Reports. 5: 102-109. DOI: 10.1007/S40429-018-0202-2 |
0.467 |
|
| 2017 |
Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K. Pharmacogenetic effects of naltrexone in individuals of East Asian descent: Human laboratory findings from a randomized trial. Alcoholism, Clinical and Experimental Research. PMID 29265379 DOI: 10.1111/Acer.13586 |
0.515 |
|
| 2017 |
Hartwell EE, Ray LA. Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers. Alcohol and Alcoholism (Oxford, Oxfordshire). 1-6. PMID 29145640 DOI: 10.1093/Alcalc/Agx088 |
0.562 |
|
| 2017 |
Cservenka A, Courtney KE, Ghahremani DG, Hutchison KE, Ray LA. Development, Initial Testing and Challenges of an Ecologically Valid Reward Prediction Error FMRI Task for Alcoholism. Alcohol and Alcoholism (Oxford, Oxfordshire). 1-8. PMID 28633363 DOI: 10.1093/Alcalc/Agx037 |
0.503 |
|
| 2017 |
Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. Journal of Substance Abuse Treatment. PMID 28527854 DOI: 10.1016/J.Jsat.2017.05.004 |
0.509 |
|
| 2017 |
Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? The American Journal of Drug and Alcohol Abuse. 1-8. PMID 28426264 DOI: 10.1080/00952990.2017.1312423 |
0.573 |
|
| 2017 |
Roche DJ, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology. PMID 28357460 DOI: 10.1007/S00213-017-4607-8 |
0.745 |
|
| 2017 |
Lim AC, Cservenka A, Ray LA. Effects of Alcohol Dependence Severity on Neural Correlates of Delay Discounting. Alcohol and Alcoholism (Oxford, Oxfordshire). 1-10. PMID 28340213 DOI: 10.1093/Alcalc/Agx015 |
0.522 |
|
| 2017 |
Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28091532 DOI: 10.1038/Npp.2017.10 |
0.822 |
|
| 2017 |
Courtney KE, Ghahremani D, Ray L. The effects of naltrexone on neural responses to methamphetamine cues Drug and Alcohol Dependence. 171: e47. DOI: 10.1016/J.Drugalcdep.2016.08.141 |
0.327 |
|
| 2016 |
Cservenka A, Yardley MM, Ray LA. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. The American Journal On Addictions. PMID 28134463 DOI: 10.1111/Ajad.12463 |
0.529 |
|
| 2016 |
Westman JG, Bujarski S, Ray LA. Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 28003245 DOI: 10.1093/Alcalc/Agw096 |
0.601 |
|
| 2016 |
Bullock K, Cservenka A, Ray LA. Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 27996310 DOI: 10.1080/00952990.2016.1257632 |
0.554 |
|
| 2016 |
Bello MS, Pang RD, Chasson GS, Ray LA, Leventhal AM. Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers. Journal of Anxiety Disorders. PMID 27769664 DOI: 10.1016/J.Janxdis.2016.10.001 |
0.328 |
|
| 2016 |
Courtney KE, Ghahremani DG, Ray LA. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity In Humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27312405 DOI: 10.1038/Npp.2016.99 |
0.323 |
|
| 2016 |
Bujarski S, Ray LA. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behaviour Research and Therapy. PMID 27266992 DOI: 10.1016/J.Brat.2016.05.008 |
0.533 |
|
| 2016 |
Green R, Bujarski S, Roche DJ, Ray LA. Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors. 61: 53-57. PMID 27240211 DOI: 10.1016/J.Addbeh.2016.05.016 |
0.763 |
|
| 2016 |
Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Current Addiction Reports. 3: 125-137. PMID 27162709 DOI: 10.1007/S40429-016-0081-3 |
0.806 |
|
| 2016 |
Squeglia LM, Brammer WA, Ray LA, Lee SS. Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Predict Alcohol Expectancy Development. Journal of Child & Adolescent Substance Abuse. 25: 159-179. PMID 27110089 DOI: 10.1080/1067828X.2014.969856 |
0.477 |
|
| 2016 |
Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 27087145 DOI: 10.1111/Acer.13064 |
0.823 |
|
| 2016 |
Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addiction Biology. PMID 26833803 DOI: 10.1111/Adb.12349 |
0.518 |
|
| 2016 |
Courtney KE, Ray LA. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Progress in Brain Research. 223: 295-310. PMID 26806782 DOI: 10.1016/Bs.Pbr.2015.07.010 |
0.324 |
|
| 2016 |
Ray LA, Bujarski S, Roche DJ. Subjective Response to Alcohol as a Research Domain Criterion. Alcoholism, Clinical and Experimental Research. 40: 6-17. PMID 26727518 DOI: 10.1111/Acer.12927 |
0.816 |
|
| 2016 |
Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: Insights into the predictive value of animal and human laboratory models Addiction Biology. DOI: 10.1111/adb.12349 |
0.41 |
|
| 2016 |
Roche DJO, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder Alcoholism: Clinical and Experimental Research. DOI: 10.1111/acer.13064 |
0.529 |
|
| 2016 |
Ray LA, Bujarski S, Roche DJO. Subjective Response to Alcohol as a Research Domain Criterion Alcoholism: Clinical and Experimental Research. 40: 6-17. DOI: 10.1111/acer.12927 |
0.384 |
|
| 2016 |
Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The association of alcohol severity and sleep quality in problem drinkers Alcohol and Alcoholism. 50: 536-541. DOI: 10.1093/alcalc/agv046 |
0.302 |
|
| 2016 |
Bacio GA, Ray LA. Patterns of Drinking Initiation Among Latino Youths: Cognitive and Contextual Explanations of the Immigrant Paradox Journal of Child & Adolescent Substance Abuse. 25: 546-556. DOI: 10.1080/1067828X.2016.1153553 |
0.422 |
|
| 2015 |
Moore AA, Karno MP, Ray L, Ramirez K, Barenstein V, Portillo MJ, Rizo P, Borok J, Liao DH, Barron J, Del Pino HE, Valenzuela A, Barry KL. Development and Preliminary Testing of a Promotora - Delivered, Spanish Language, Counseling Intervention for Heavy Drinking among Male, Latino Day Laborers. Journal of Substance Abuse Treatment. PMID 26738641 DOI: 10.1016/J.Jsat.2015.11.003 |
0.396 |
|
| 2015 |
Cummings JR, Ray LA, Tomiyama AJ. Food-alcohol competition: As young females eat more food, do they drink less alcohol? Journal of Health Psychology. PMID 26542418 DOI: 10.1177/1359105315611955 |
0.473 |
|
| 2015 |
Yardley MM, Mirbaba MM, Ray LA. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. Cns Drugs. 29: 833-45. PMID 26507831 DOI: 10.1007/S40263-015-0284-5 |
0.516 |
|
| 2015 |
Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA. Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addiction Biology. PMID 26435524 DOI: 10.1111/Adb.12314 |
0.766 |
|
| 2015 |
Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and Environmental Predictors of Alcohol Use in Asian American Young Adults. Journal of Studies On Alcohol and Drugs. 76: 690-699. PMID 26402349 DOI: 10.15288/Jsad.2015.76.690 |
0.551 |
|
| 2015 |
Bujarski S, Hutchison KE, Prause N, Ray LA. Functional significance of subjective response to alcohol across levels of alcohol exposure. Addiction Biology. PMID 26256114 DOI: 10.1111/Adb.12293 |
0.588 |
|
| 2015 |
Courtney KE, Ghahremani DG, Ray LA. The effect of alcohol priming on neural markers of alcohol cue-reactivity. The American Journal of Drug and Alcohol Abuse. 41: 300-8. PMID 26125586 DOI: 10.3109/00952990.2015.1044608 |
0.58 |
|
| 2015 |
Bidwell LC, Knopik VS, Audrain-McGovern J, Glynn TR, Spillane NS, Ray LA, Riggs NR, Guillot CR, Pang RD, Leventhal AM. Novelty Seeking as a Phenotypic Marker of Adolescent Substance Use. Substance Abuse : Research and Treatment. 9: 1-10. PMID 26106262 DOI: 10.4137/Sart.S22440 |
0.348 |
|
| 2015 |
Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The Association of Alcohol Severity and Sleep Quality in Problem Drinkers. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 536-41. PMID 26018218 DOI: 10.1093/Alcalc/Agv046 |
0.473 |
|
| 2015 |
Bujarski S, Hutchison KE, Roche DJ, Ray LA. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcoholism, Clinical and Experimental Research. 39: 1193-202. PMID 26010049 DOI: 10.1111/Acer.12737 |
0.814 |
|
| 2015 |
Roche DJ, Ray LA. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics. 16: 721-36. PMID 25950242 DOI: 10.2217/Pgs.14.143 |
0.827 |
|
| 2015 |
Allen VC, Myers HF, Ray L. The Association Between Alcohol Consumption and Condom Use: Considering Correlates of HIV Risk Among Black Men Who Have Sex with Men. Aids and Behavior. 19: 1689-700. PMID 25935215 DOI: 10.1007/S10461-015-1075-1 |
0.498 |
|
| 2015 |
Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacology, Biochemistry, and Behavior. 134: 92-8. PMID 25933795 DOI: 10.1016/J.Pbb.2015.04.013 |
0.741 |
|
| 2015 |
Ray LA, Bujarski S. Mechanisms of topiramate effects: refining medications development for alcoholism. Addiction Biology. PMID 25876675 DOI: 10.1111/Adb.12226 |
0.522 |
|
| 2015 |
Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study. Experimental and Clinical Psychopharmacology. 23: 81-9. PMID 25844632 DOI: 10.1037/A0038861 |
0.734 |
|
| 2015 |
Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25801501 DOI: 10.1038/Npp.2015.83 |
0.761 |
|
| 2015 |
Owens MM, Ray LA, MacKillop J. Behavioral economic analysis of stress effects on acute motivation for alcohol. Journal of the Experimental Analysis of Behavior. 103: 77-86. PMID 25413719 DOI: 10.1002/Jeab.114 |
0.53 |
|
| 2015 |
Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. The American Journal of Drug and Alcohol Abuse. 41: 35-44. PMID 24949564 DOI: 10.3109/00952990.2014.927881 |
0.382 |
|
| 2015 |
Roche DJO, Ray LA. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment Pharmacogenomics. 16: 721-736. DOI: 10.2217/pgs.14.143 |
0.452 |
|
| 2015 |
Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and environmental predictors of alcohol use in Asian American young adults Journal of Studies On Alcohol and Drugs. 76: 690-699. DOI: 10.15288/jsad.2015.76.690 |
0.358 |
|
| 2014 |
Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence. 143: 11-21. PMID 25176528 DOI: 10.1016/J.Drugalcdep.2014.08.003 |
0.342 |
|
| 2014 |
Ray LA, Roche DJ, Heinzerling K, Shoptaw S. Opportunities for the development of neuroimmune therapies in addiction. International Review of Neurobiology. 118: 381-401. PMID 25175870 DOI: 10.1016/B978-0-12-801284-0.00012-9 |
0.76 |
|
| 2014 |
Bujarski S, Ray LA. Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addictive Behaviors. 39: 1723-9. PMID 25117849 DOI: 10.1016/J.Addbeh.2014.07.019 |
0.604 |
|
| 2014 |
Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug and Alcohol Dependence. 142: 127-32. PMID 24975477 DOI: 10.1016/J.Drugalcdep.2014.06.004 |
0.802 |
|
| 2014 |
Courtney KE, Ghahremani DG, London ED, Ray LA. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and Alcohol Dependence. 141: 21-6. PMID 24880692 DOI: 10.1016/J.Drugalcdep.2014.04.026 |
0.531 |
|
| 2014 |
Ashenhurst JR, Bujarski S, Jentsch JD, Ray LA. Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): moderation by alcohol problem severity. Experimental and Clinical Psychopharmacology. 22: 298-306. PMID 24840639 DOI: 10.1037/A0036837 |
0.463 |
|
| 2014 |
Bujarski S, Ray LA. Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. Drug and Alcohol Dependence. 140: 161-7. PMID 24837580 DOI: 10.1016/J.Drugalcdep.2014.04.015 |
0.56 |
|
| 2014 |
Bacio G, Moore A, Karno M, Ray L. Determinants of problem drinking and depression among Latino Day laborers. Substance Use & Misuse. 49: 1039-48. PMID 24779503 DOI: 10.3109/10826084.2013.852577 |
0.359 |
|
| 2014 |
DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. Journal of Studies On Alcohol and Drugs. 75: 438-46. PMID 24766756 DOI: 10.15288/Jsad.2014.75.438 |
0.497 |
|
| 2014 |
Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology. 231: 3843-53. PMID 24733235 DOI: 10.1007/S00213-014-3519-0 |
0.381 |
|
| 2014 |
Miranda R, Monti PM, Ray L, Treloar HR, Reynolds EK, Ramirez J, Chun T, Gwaltney CJ, Justus A, Tidey J, Blanchard A, Magill M. Characterizing subjective responses to alcohol among adolescent problem drinkers. Journal of Abnormal Psychology. 123: 117-29. PMID 24661164 DOI: 10.1037/A0035328 |
0.55 |
|
| 2014 |
MacKillop J, Amlung MT, Acker J, Gray JC, Brown CL, Murphy JG, Ray LA, Sweet LH. The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1988-95. PMID 24584331 DOI: 10.1038/Npp.2014.47 |
0.499 |
|
| 2014 |
Roche DJ, Bujarski S, Moallem NR, Guzman I, Shapiro JR, Ray LA. Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology. 231: 2889-97. PMID 24500677 DOI: 10.1007/S00213-014-3465-X |
0.719 |
|
| 2014 |
Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol and Alcoholism (Oxford, Oxfordshire). 49: 261-70. PMID 24421289 DOI: 10.1093/Alcalc/Agt183 |
0.539 |
|
| 2014 |
Courtney KE, Ray LA. Subjective responses to alcohol in the lab predict neural responses to alcohol cues. Journal of Studies On Alcohol and Drugs. 75: 124-35. PMID 24411804 DOI: 10.15288/Jsad.2014.75.124 |
0.584 |
|
| 2014 |
Bacio GA, Lunny KF, Webb JN, Ray LA. Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 96-101. PMID 24313247 DOI: 10.1111/J.1521-0391.2013.12071.X |
0.592 |
|
| 2014 |
Lin JC, Karno MP, Grella CE, Ray LA, Liao DH, Moore AA. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1356-63. PMID 24021218 DOI: 10.1016/J.Jagp.2013.07.005 |
0.464 |
|
| 2014 |
Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcoholism, Clinical and Experimental Research. 38: 78-89. PMID 23876228 DOI: 10.1111/Acer.12136 |
0.505 |
|
| 2014 |
Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addiction Biology. 19: 941-54. PMID 23489253 DOI: 10.1111/Adb.12050 |
0.588 |
|
| 2013 |
Courtney KE, Ashenhurst J, Bacio G, Moallem N, Bujarski S, Hartwell E, Ray LA. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory. Journal of Studies On Alcohol and Drugs. 74: 797-802. PMID 23948540 DOI: 10.15288/Jsad.2013.74.797 |
0.59 |
|
| 2013 |
Moallem NR, Courtney KE, Bacio GA, Ray LA. Modeling alcohol use disorder severity: an integrative structural equation modeling approach. Frontiers in Psychiatry. 4: 75. PMID 23908635 DOI: 10.3389/Fpsyt.2013.00075 |
0.562 |
|
| 2013 |
Hartwell EE, Ray LA. Sex moderates stress reactivity in heavy drinkers. Addictive Behaviors. 38: 2643-6. PMID 23899426 DOI: 10.1016/J.Addbeh.2013.06.016 |
0.425 |
|
| 2013 |
AlGhatrif M, Markides KS, Kuo YF, Ray LA, Moore AA. The effect of prevalent cardiovascular conditions on the association between alcohol consumption and mortality among older Mexican American men. Ethnicity & Disease. 23: 168-74. PMID 23530297 |
0.346 |
|
| 2013 |
Ray LA, Sehl M, Bujarski S, Hutchison K, Blaine S, Enoch MA. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G × E effects. Genes, Brain, and Behavior. 12: 361-9. PMID 23473364 DOI: 10.1111/Gbb.12032 |
0.458 |
|
| 2013 |
Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K. The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence. 131: 136-42. PMID 23298651 DOI: 10.1016/J.Drugalcdep.2012.12.015 |
0.328 |
|
| 2013 |
Courtney KE, Ghahremani DG, Ray LA. Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addiction Biology. 18: 593-604. PMID 23240858 DOI: 10.1111/Adb.12013 |
0.519 |
|
| 2013 |
Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcoholism, Clinical and Experimental Research. 37: E116-24. PMID 23240711 DOI: 10.1111/J.1530-0277.2012.01916.X |
0.595 |
|
| 2013 |
Bujarski S, O'Malley SS, Lunny K, Ray LA. The effects of drinking goal on treatment outcome for alcoholism. Journal of Consulting and Clinical Psychology. 81: 13-22. PMID 23231573 DOI: 10.1037/A0030886 |
0.542 |
|
| 2013 |
Miranda R, Reynolds E, Ray L, Justus A, Knopik VS, McGeary J, Meyerson LA. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcoholism, Clinical and Experimental Research. 37: 325-31. PMID 23136901 DOI: 10.1111/J.1530-0277.2012.01897.X |
0.364 |
|
| 2012 |
Ashenhurst JR, Bujarski S, Ray LA. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacology, Biochemistry, and Behavior. 103: 253-9. PMID 22954510 DOI: 10.1016/J.Pbb.2012.08.019 |
0.503 |
|
| 2012 |
Tartter MA, Ray LA. A prospective study of stress and alcohol craving in heavy drinkers. Pharmacology, Biochemistry, and Behavior. 101: 625-31. PMID 22446386 DOI: 10.1016/J.Pbb.2012.03.007 |
0.55 |
|
| 2012 |
Moallem NR, Ray LA. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addictive Behaviors. 37: 871-4. PMID 22445419 DOI: 10.1016/J.Addbeh.2012.03.002 |
0.498 |
|
| 2012 |
Bujarski S, MacKillop J, Ray LA. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Experimental and Clinical Psychopharmacology. 20: 181-90. PMID 22429255 DOI: 10.1037/A0027379 |
0.577 |
|
| 2012 |
Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research. Alcoholism, Clinical and Experimental Research. 36: 972-83. PMID 22309888 DOI: 10.1111/J.1530-0277.2011.01704.X |
0.72 |
|
| 2012 |
Ray LA, Courtney KE, Bujarski S, Squeglia LM. Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics. 13: 129-32. PMID 22256863 DOI: 10.2217/Pgs.11.173 |
0.574 |
|
| 2012 |
Heinzerling KG, McCracken JT, Swanson AN, Ray LA, Shoptaw SJ. COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. Journal of Clinical Psychopharmacology. 32: 135-7. PMID 22217949 DOI: 10.1097/Jcp.0B013E318240A48E |
0.365 |
|
| 2012 |
Courtney KE, Arellano R, Barkley-Levenson E, Gálvan A, Poldrack RA, Mackillop J, Jentsch JD, Ray LA. The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcoholism, Clinical and Experimental Research. 36: 923-31. PMID 22091877 DOI: 10.1111/J.1530-0277.2011.01635.X |
0.544 |
|
| 2012 |
Moallem N, Ray LA. Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study. Pharmacology, Biochemistry, and Behavior. 100: 490-3. PMID 22037407 DOI: 10.1016/J.Pbb.2011.10.012 |
0.523 |
|
| 2012 |
Ray LA, Bujarski S, Chin PF, Miotto K. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 445-55. PMID 21900886 DOI: 10.1038/Npp.2011.192 |
0.508 |
|
| 2012 |
Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcoholism, Clinical and Experimental Research. 36: 385-94. PMID 21895723 DOI: 10.1111/J.1530-0277.2011.01633.X |
0.544 |
|
| 2012 |
Ray LA. Clinical Neuroscience of Addiction: Applications to Psychological Science and Practice Clinical Psychology: Science and Practice. 19: 154-166. DOI: 10.1111/J.1468-2850.2012.01280.X |
0.321 |
|
| 2012 |
Miotto K, Heydari A, Tartter M, Chang E, Thomas PS, Ray LA. Adolescent Alcohol Use Clinical Handbook of Adolescent Addiction. 177-189. DOI: 10.1002/9781118340851.ch18 |
0.397 |
|
| 2011 |
Tartter MA, Ray LA. The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms. Frontiers in Psychiatry. 2: 49. PMID 21852976 DOI: 10.3389/Fpsyt.2011.00049 |
0.515 |
|
| 2011 |
Ashenhurst JR, Jentsch JD, Ray LA. Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Experimental and Clinical Psychopharmacology. 19: 361-70. PMID 21707191 DOI: 10.1037/A0024412 |
0.491 |
|
| 2011 |
Ray LA, Chin PF, Heydari A, Miotto K. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology. 217: 341-51. PMID 21487653 DOI: 10.1007/S00213-011-2287-3 |
0.502 |
|
| 2011 |
Ferriter C, Ray LA. Binge eating and binge drinking: an integrative review. Eating Behaviors. 12: 99-107. PMID 21385638 DOI: 10.1016/J.Eatbeh.2011.01.001 |
0.372 |
|
| 2011 |
MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munafò MR. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology. 216: 305-21. PMID 21373791 DOI: 10.1007/S00213-011-2229-0 |
0.317 |
|
| 2011 |
Ray LA, Hart E, Chelminski I, Young D, Zimmerman M. Clinical correlates of desire for treatment for current alcohol dependence among patients with a primary psychiatric disorder. The American Journal of Drug and Alcohol Abuse. 37: 105-10. PMID 21219256 DOI: 10.3109/00952990.2010.540284 |
0.594 |
|
| 2011 |
Ray LA, Hart EJ, Chin PF. Self-Rating of the Effects of Alcohol (SRE): Predictive utility and reliability across interview and self-report administrations. Addictive Behaviors. 36: 241-3. PMID 21095629 DOI: 10.1016/J.Addbeh.2010.10.009 |
0.505 |
|
| 2011 |
Ray LA. Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcoholism, Clinical and Experimental Research. 35: 166-74. PMID 21039637 DOI: 10.1111/J.1530-0277.2010.01333.X |
0.454 |
|
| 2011 |
Ray LA, Primack J, Chelminski I, Young D, Zimmerman M. Diagnostic and Clinical Profiles of Treatment-Seeking Men With and Without Substance Use Disorders Psychology of Men and Masculinity. 12: 158-165. DOI: 10.1037/A0020169 |
0.35 |
|
| 2010 |
Ray LA, Krull JL, Leggio L. The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Frontiers in Psychiatry. 1: 26. PMID 21423437 DOI: 10.3389/Fpsyt.2010.00026 |
0.573 |
|
| 2010 |
Leventhal AM, Brightman M, Ameringer KJ, Greenberg J, Mickens L, Ray LA, Sun P, Sussman S. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Experimental and Clinical Psychopharmacology. 18: 562-9. PMID 21186931 DOI: 10.1037/A0021964 |
0.308 |
|
| 2010 |
Ray LA, Heydari A, Zorick T. Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug and Alcohol Review. 29: 568-75. PMID 20887583 DOI: 10.1111/J.1465-3362.2010.00185.X |
0.605 |
|
| 2010 |
MacKillop J, O'Hagen S, Lisman SA, Murphy JG, Ray LA, Tidey JW, McGeary JE, Monti PM. Behavioral economic analysis of cue-elicited craving for alcohol. Addiction (Abingdon, England). 105: 1599-607. PMID 20626376 DOI: 10.1111/J.1360-0443.2010.03004.X |
0.584 |
|
| 2010 |
Ray LA, Mackillop J, Monti PM. Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Substance Use & Misuse. 45: 1742-65. PMID 20590398 DOI: 10.3109/10826084.2010.482427 |
0.585 |
|
| 2010 |
Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL. Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcoholism, Clinical and Experimental Research. 34: 1479-87. PMID 20528823 DOI: 10.1111/J.1530-0277.2010.01233.X |
0.483 |
|
| 2010 |
Ray LA, Hutchison KE, Tartter M. Application of human laboratory models to pharmacotherapy development for alcohol dependence. Current Pharmaceutical Design. 16: 2149-58. PMID 20482505 DOI: 10.2174/138161210791516422 |
0.593 |
|
| 2010 |
Ray LA, Chin PF, Miotto K. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. Cns & Neurological Disorders Drug Targets. 9: 13-22. PMID 20201811 DOI: 10.2174/187152710790966704 |
0.573 |
|
| 2010 |
Ray LA, Miranda R, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. Journal of Abnormal Psychology. 119: 115-25. PMID 20141248 DOI: 10.1037/A0017550 |
0.541 |
|
| 2010 |
MacKillop J, Miranda R, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JE, Swift RM, Tidey JW, Gwaltney CJ. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. Journal of Abnormal Psychology. 119: 106-14. PMID 20141247 DOI: 10.1037/A0017513 |
0.594 |
|
| 2010 |
Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM. Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcoholism, Clinical and Experimental Research. 34: 112-22. PMID 19860800 DOI: 10.1111/J.1530-0277.2009.01073.X |
0.553 |
|
| 2009 |
Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M. Young Investigator Award symposium. Alcohol (Fayetteville, N.Y.). 43: 499-508. PMID 19913193 DOI: 10.1016/J.Alcohol.2009.06.004 |
0.522 |
|
| 2009 |
Ray LA, Capone C, Sheets E, Young D, Chelminski I, Zimmerman M. Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Research. 170: 278-81. PMID 19900714 DOI: 10.1016/J.Psychres.2008.10.015 |
0.449 |
|
| 2009 |
Ray LA, MacKillop J, Leventhal A, Hutchison KE. Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcoholism, Clinical and Experimental Research. 33: 2154-61. PMID 19764932 DOI: 10.1111/J.1530-0277.2009.01053.X |
0.576 |
|
| 2009 |
Ray LA, Oslin DW. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug and Alcohol Dependence. 105: 256-8. PMID 19717248 DOI: 10.1016/J.Drugalcdep.2009.07.006 |
0.424 |
|
| 2009 |
Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S. Relations between anhedonia and smoking motivation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 1047-54. PMID 19571250 DOI: 10.1093/Ntr/Ntp098 |
0.316 |
|
| 2009 |
Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. Journal of Studies On Alcohol and Drugs. 70: 516-27. PMID 19515291 DOI: 10.15288/Jsad.2009.70.516 |
0.403 |
|
| 2009 |
Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism, Clinical and Experimental Research. 33: 1539-44. PMID 19485973 DOI: 10.1111/J.1530-0277.2009.00982.X |
0.462 |
|
| 2009 |
Ray LA, Hutchison KE. Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcoholism, Clinical and Experimental Research. 33: 1382-90. PMID 19426171 DOI: 10.1111/J.1530-0277.2009.00968.X |
0.563 |
|
| 2009 |
Ray LA, Hutchison KE, Leventhal AM, Miranda R, Francione C, Chelminski I, Young D, Zimmerman M. Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addictive Behaviors. 34: 587-92. PMID 19362427 DOI: 10.1016/J.Addbeh.2009.03.028 |
0.602 |
|
| 2009 |
Ray LA, Miranda R, MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, Gwaltney C, Swift RW, Monti PM. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Experimental and Clinical Psychopharmacology. 17: 122-9. PMID 19331489 DOI: 10.1037/A0015700 |
0.44 |
|
| 2009 |
Mackillop J, Murphy JG, Tidey JW, Kahler CW, Ray LA, Bickel WK. Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology. 203: 33-40. PMID 18925387 DOI: 10.1007/S00213-008-1367-5 |
0.547 |
|
| 2009 |
Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacology, Biochemistry, and Behavior. 91: 489-94. PMID 18824022 DOI: 10.1016/J.Pbb.2008.09.004 |
0.563 |
|
| 2009 |
Ray LA, Bryan A, Mackillop J, McGeary J, Hesterberg K, Hutchison KE. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addiction Biology. 14: 238-44. PMID 18715282 DOI: 10.1111/J.1369-1600.2008.00120.X |
0.543 |
|
| 2008 |
Ray LA, Hutchison KE, MacKillop J, Miranda R, Audette A, Swift R, Monti PM. Effects of naltrexone during the descending limb of the blood alcohol curve. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 257-64. PMID 18612879 DOI: 10.1080/10550490802138400 |
0.595 |
|
| 2008 |
Ray LA, Kahler CW, Young D, Chelminski I, Zimmerman M. The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. Journal of Studies On Alcohol and Drugs. 69: 496-9. PMID 18612564 DOI: 10.15288/Jsad.2008.69.496 |
0.504 |
|
| 2008 |
Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcoholism, Clinical and Experimental Research. 32: 1113-23. PMID 18540916 DOI: 10.1111/J.1530-0277.2008.00692.X |
0.566 |
|
| 2008 |
Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, Zimmerman M. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 218-23. PMID 18463999 DOI: 10.1080/10550490802019774 |
0.333 |
|
| 2008 |
Ray LA, Miranda R, Chelminski I, Young D, Zimmerman M. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug and Alcohol Dependence. 96: 187-91. PMID 18430524 DOI: 10.1016/J.Drugalcdep.2008.03.002 |
0.578 |
|
| 2008 |
MacKillop J, Murphy JG, Ray LA, Eisenberg DT, Lisman SA, Lum JK, Wilson DS. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Experimental and Clinical Psychopharmacology. 16: 57-65. PMID 18266552 DOI: 10.1037/1064-1297.16.1.57 |
0.339 |
|
| 2008 |
Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcoholism, Clinical and Experimental Research. 32: 489-97. PMID 18215213 DOI: 10.1111/J.1530-0277.2007.00592.X |
0.58 |
|
| 2008 |
Haughey HM, Ray LA, Finan P, Villanueva R, Niculescu M, Hutchison KE. Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression. Genes, Brain, and Behavior. 7: 447-54. PMID 18005236 DOI: 10.1111/J.1601-183X.2007.00369.X |
0.563 |
|
| 2008 |
Miranda R, Rohsenow DJ, Monti PM, Tidey J, Ray L. Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addictive Behaviors. 33: 347-53. PMID 17913381 DOI: 10.1016/J.Addbeh.2007.09.011 |
0.328 |
|
| 2007 |
Ray LA, MacKillop J, Hutchison KE. Pharmacogenetics of the µ-opioid receptor and the treatment of addictions. Personalized Medicine. 4: 217-220. PMID 29788631 DOI: 10.2217/17410541.4.2.217 |
0.348 |
|
| 2007 |
Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Archives of General Psychiatry. 64: 1069-77. PMID 17768272 DOI: 10.1001/Archpsyc.64.9.1069 |
0.593 |
|
| 2007 |
Ray LA, Rhee SH, Stallings MC, Knopik V, Hutchison KE. Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 10: 546-53. PMID 17708695 DOI: 10.1375/Twin.10.4.546 |
0.311 |
|
| 2007 |
Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology. 193: 449-56. PMID 17484067 DOI: 10.1007/S00213-007-0794-Z |
0.59 |
|
| 2007 |
Ray LA, Meskew-Stacer S, Hutchison KE. The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. Journal of Studies On Alcohol and Drugs. 68: 379-84. PMID 17446977 DOI: 10.15288/Jsad.2007.68.379 |
0.596 |
|
| 2007 |
Bryan A, Ray LA, Cooper ML. Alcohol use and protective sexual behaviors among high-risk adolescents. Journal of Studies On Alcohol and Drugs. 68: 327-35. PMID 17446971 DOI: 10.15288/Jsad.2007.68.327 |
0.534 |
|
| 2006 |
Ray LA, McGeary J, Marshall E, Hutchison KE. Risk factors for alcohol misuse: examining heart rate reactivity to alcohol, alcohol sensitivity, and personality constructs. Addictive Behaviors. 31: 1959-73. PMID 16466861 DOI: 10.1016/J.Addbeh.2006.01.010 |
0.572 |
|
| 2006 |
Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1310-7. PMID 16237394 DOI: 10.1038/Sj.Npp.1300917 |
0.554 |
|
| 2006 |
Ray LA, Hutchison KE, Bryan A. Psychosocial predictors of treatment outcome, dropout, and change processes in a pharmacological clinical trial for alcohol dependence Addictive Disorders and Their Treatment. 5: 179-190. DOI: 10.1097/01.Adt.0000210701.63165.5A |
0.522 |
|
| 2005 |
Hines LM, Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues in Clinical Neuroscience. 7: 153-63. PMID 16262210 |
0.521 |
|
| 2004 |
Ray LA, Hutchison KE. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcoholism, Clinical and Experimental Research. 28: 1789-95. PMID 15608594 DOI: 10.1097/01.Alc.0000148114.34000.B9 |
0.559 |
|
| 2004 |
Fromme K, de Wit H, Hutchison KE, Ray L, Corbin WR, Cook TA, Wall TL, Goldman D. Biological and behavioral markers of alcohol sensitivity. Alcoholism, Clinical and Experimental Research. 28: 247-56. PMID 15112932 DOI: 10.1097/01.Alc.0000113420.28472.25 |
0.556 |
|
| Show low-probability matches. |